Penghui Yang

Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications

Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs.

Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs.

Journal: International journal of nanomedicine
Published: July 09, 2024

Combination Immunotherapy of Oncolytic Flu-Vectored Virus and Programmed Cell Death 1 Blockade Enhances Antitumor Activity in Hepatocellular Carcinoma.

Combination Immunotherapy of Oncolytic Flu-Vectored Virus and Programmed Cell Death 1 Blockade Enhances Antitumor Activity in Hepatocellular Carcinoma.

Journal: Human gene therapy
Published: February 22, 2024

Retraction: Decreased long intergenic noncoding RNA P7 predicts unfavorable prognosis and promotes tumor proliferation via the modulation of the STAT1-MAPK pathway in hepatocellular carcinoma.

Retraction: Decreased long intergenic noncoding RNA P7 predicts unfavorable prognosis and promotes tumor proliferation via the modulation of the STAT1-MAPK pathway in hepatocellular carcinoma.

Journal: Oncotarget
Published: January 16, 2024

Protective efficacy of a novel recombinant influenza virus carrying partial human metapneumovirus F protein epitopes.

Protective efficacy of a novel recombinant influenza virus carrying partial human metapneumovirus F protein epitopes.

Journal: Virulence
Published: November 17, 2023

A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response.

A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response.

Journal: Human gene therapy
Published: August 30, 2023

A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge.

A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge.

Journal: Virology
Published: August 29, 2023

Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.

Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.

Journal: Frontiers in immunology
Published: June 06, 2023

Cold-adapted influenza-vectored RSV vaccine protects BALB/c mice and cotton rats from RSV challenge.

Cold-adapted influenza-vectored RSV vaccine protects BALB/c mice and cotton rats from RSV challenge.

Journal: Journal of medical virology
Published: March 23, 2023

An Engineered Influenza a Virus Expressing the Co-Stimulator OX40L as an Oncolytic Agent Against Hepatocellular Carcinoma.

An Engineered Influenza a Virus Expressing the Co-Stimulator OX40L as an Oncolytic Agent Against Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma
Published: March 03, 2023

mRNA vaccines: A novel weapon to control infectious diseases.

mRNA vaccines: A novel weapon to control infectious diseases.

Journal: Frontiers in microbiology
Published: August 01, 2022

An OX40L mRNA vaccine inhibits the growth of hepatocellular carcinoma.

An OX40L mRNA vaccine inhibits the growth of hepatocellular carcinoma.

Journal: Frontiers in oncology
Published: June 22, 2022

mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.

mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.

Journal: Frontiers in immunology
Published: March 01, 2022
Showing 1-12 of 55

Last Updated: 09/26/2026